Hepatitis A Virus, ABS-IgM (HAV IgM)

Code

2860

Principle

HAV IgM assay is indicated for use as an aid in the diagnosis of acute or recent hepatitis A viral infection.

Preanalytical

1 mL Serum Refrigerated

Turn Around Time

1 day

Methodology

Chemiluminescent microparticle immunoassay (CMIA)

Limitations

 Specimens from patients who have received preparations of mouse monoclonal antibodies for diagnosis or therapy may contain human anti-mouse antibodies (HAMA). Specimens containing HAMA may produce anomalous values when tested.